Repros Therapeutics Inc (RPRX)

[docbanker]

I'm glad. I feel like if this level of not only diligence but in my mind persistent doubt and "nitpicking" were done on a number of other names in the sector, I suspect the holdings of many of these posters would be dramatically lower.

For MNTA, Dew and whoever else cant put together a cognizant argument for a drug who already received a "not approvable" and they cheer when there is short covering from $8-10. Now its 8s again. For RPRX, we beat the same dead horse over and over and no one is satisfied. P values of 10 to the mius 7 or whatever are challenged routinely. The hurdle is different.